|
 |
|
|||||||
|
|||||||||
© 2001 by the American Diabetes Association, Inc.
Transgenic Overexpression of Leptin Rescues Insulin Resistance and Diabetes in a Mouse Model of Lipoatrophic Diabetes
1 Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan
2 Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland
Lipoatrophic diabetes is caused by a deficiency of adipose tissue and is characterized by severe insulin resistance, hypoleptinemia, and hyperphagia. The A-ZIP/F-1 mouse (A-ZIPTg/+) is a model of severe lipoatrophic diabetes and is insulin resistant, hypoleptinemic, hyperphagic, and shows severe hepatic steatosis. We have also produced transgenic "skinny" mice that have hepatic overexpression of leptin (LepTg/+) and no adipocyte triglyceride stores, and are hypophagic and show increased insulin sensitivity. To explore the pathophysiological and therapeutic roles of leptin in lipoatrophic diabetes, we crossed LepTg/+ and A-ZIPTg/+ mice, producing doubly transgenic mice (LepTg/+:A-ZIPTg/+) virtually lacking adipose tissue but having greatly elevated leptin levels. The LepTg/+:A-ZIPTg/+ mice were hypophagic and showed improved hepatic steatosis. Glucose and insulin tolerance tests revealed increased insulin sensitivity, comparable to LepTg/+ mice. These effects were stable over at least 6 months of age. Pair-feeding the A-ZIPTg/+ mice to the amount of food consumed by LepTg/+:A-ZIPTg/+ mice did not improve their insulin resistance, diabetes, or hepatic steatosis, demonstrating that the beneficial effects of leptin were not due to the decreased food intake. Continuous leptin administration that elevates plasma leptin concentrations to those of LepTg/+:A-ZIPTg/+ mice also effectively improved hepatic steatosis and the disorder of glucose and lipid metabolism in A-ZIP/F-1 mice. These data demonstrate that leptin can improve the insulin resistance and diabetes of a mouse model of severe lipoatrophic diabetes, suggesting that leptin may be therapeutically useful in the long-term treatment of lipoatrophic diabetes.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Qatanani and M. A. Lazar Mechanisms of obesity-associated insulin resistance: many choices on the menu Genes & Dev., June 15, 2007; 21(12): 1443 - 1455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ebihara, T. Kusakabe, M. Hirata, H. Masuzaki, F. Miyanaga, N. Kobayashi, T. Tanaka, H. Chusho, T. Miyazawa, T. Hayashi, et al. Efficacy and Safety of Leptin-Replacement Therapy and Possible Mechanisms of Leptin Actions in Patients with Generalized Lipodystrophy J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 532 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Utzschneider and D. L. Trence Effectiveness of Gastric Bypass Surgery in a Patient With Familial Partial Lipodystrophy. Diabetes Care, June 1, 2006; 29(6): 1380 - 1382. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Toyoshima, O. Gavrilova, S. Yakar, W. Jou, S. Pack, Z. Asghar, M. B. Wheeler, and D. LeRoith Leptin Improves Insulin Resistance and Hyperglycemia in a Mouse Model of Type 2 Diabetes Endocrinology, September 1, 2005; 146(9): 4024 - 4035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tanaka, S. Hidaka, H. Masuzaki, S. Yasue, Y. Minokoshi, K. Ebihara, H. Chusho, Y. Ogawa, T. Toyoda, K. Sato, et al. Skeletal Muscle AMP-Activated Protein Kinase Phosphorylation Parallels Metabolic Phenotype in Leptin Transgenic Mice Under Dietary Modification Diabetes, August 1, 2005; 54(8): 2365 - 2374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hida, J. Wada, J. Eguchi, H. Zhang, M. Baba, A. Seida, I. Hashimoto, T. Okada, A. Yasuhara, A. Nakatsuka, et al. Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity PNAS, July 26, 2005; 102(30): 10610 - 10615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Javor, E. K. Cochran, C. Musso, J. R. Young, A. M. DePaoli, and P. Gorden Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy Diabetes, July 1, 2005; 54(7): 1994 - 2002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Schwartz and D. Porte Jr. Diabetes, Obesity, and the Brain Science, January 21, 2005; 307(5708): 375 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Longo, W. S. Wright, S. Kang, I. Gerin, S.-H. Chiang, P. C. Lucas, M. R. Opp, and O. A. MacDougald Wnt10b Inhibits Development of White and Brown Adipose Tissues J. Biol. Chem., August 20, 2004; 279(34): 35503 - 35509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Genetically Modified Animals in Endocrinology Endocr. Rev., June 1, 2004; 25(3): 512 - 519. [Full Text] [PDF]
|
|
|
|
|
|
K. Ebihara, T. Kusakabe, H. Masuzaki, N. Kobayashi, T. Tanaka, H. Chusho, F. Miyanaga, T. Miyazawa, T. Hayashi, K. Hosoda, et al. Gene and Phenotype Analysis of Congenital Generalized Lipodystrophy in Japanese: A Novel Homozygous Nonsense Mutation in Seipin Gene J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2360 - 2364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. den Boer, P.J. Voshol, F. Kuipers, L.M. Havekes, and J.A. Romijn Hepatic Steatosis: A Mediator of the Metabolic Syndrome. Lessons From Animal Models Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 644 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Elefteriou, S. Takeda, K. Ebihara, J. Magre, N. Patano, C. Ae Kim, Y. Ogawa, X. Liu, S. M. Ware, W. J. Craigen, et al. Serum leptin level is a regulator of bone mass PNAS, March 2, 2004; 101(9): 3258 - 3263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Havel Update on Adipocyte Hormones: Regulation of Energy Balance and Carbohydrate/Lipid Metabolism Diabetes, February 1, 2004; 53(90001): S143 - 151. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. F. Chehab, J. Qiu, and S. Ogus The Use of Animal Models to Dissect the Biology of Leptin Recent Prog. Horm. Res., January 1, 2004; 59(1): 245 - 266. [Abstract] [Full Text]
|
|
|
|
|
|
C. Colombo, M. Haluzik, J. J. Cutson, K. R. Dietz, B. Marcus-Samuels, C. Vinson, O. Gavrilova, and M. L. Reitman Opposite Effects of Background Genotype on Muscle and Liver Insulin Sensitivity of Lipoatrophic Mice. ROLE OF TRIGLYCERIDE CLEARANCE J. Biol. Chem., January 31, 2003; 278(6): 3992 - 3999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Freemark Pharmacologic Approaches to the Prevention of Type 2 Diabetes in High Risk Pediatric Patients J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 3 - 13. [Full Text] [PDF]
|
|
|
|
|
|
V. Simha, L. S. Szczepaniak, A. J. Wagner, A. M. DePaoli, and A. Garg Effect of Leptin Replacement on Intrahepatic and Intramyocellular Lipid Content in Patients With Generalized Lipodystrophy Diabetes Care, January 1, 2003; 26(1): 30 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Laustsen, M. D. Michael, B. E. Crute, S. E. Cohen, K. Ueki, R. N. Kulkarni, S. R. Keller, G. E. Lienhard, and C. R. Kahn Lipoatrophic diabetes in Irs1-/-/Irs3-/- double knockout mice Genes & Dev., December 15, 2002; 16(24): 3213 - 3222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Chen, S. J. Stone, P. Zhou, K. K. Buhman, and R. V. Farese Jr Dissociation of Obesity and Impaired Glucose Disposal in Mice Overexpressing Acyl Coenzyme A:Diacylglycerol Acyltransferase 1 in White Adipose Tissue Diabetes, November 1, 2002; 51(11): 3189 - 3195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ariyasu, K. Takaya, H. Hosoda, H. Iwakura, K. Ebihara, K. Mori, Y. Ogawa, K. Hosoda, T. Akamizu, M. Kojima, et al. Delayed Short-Term Secretory Regulation of Ghrelin in Obese Animals: Evidenced by a Specific RIA for the Active Form of Ghrelin Endocrinology, September 1, 2002; 143(9): 3341 - 3350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Colombo, J. J. Cutson, T. Yamauchi, C. Vinson, T. Kadowaki, O. Gavrilova, and M. L. Reitman Transplantation of Adipose Tissue Lacking Leptin Is Unable to Reverse the Metabolic Abnormalities Associated With Lipoatrophy Diabetes, September 1, 2002; 51(9): 2727 - 2733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. CEDDIA, H. A. KOISTINEN, J. R. ZIERATH, and G. SWEENEY Analysis of paradoxical observations on the association between leptin and insulin resistance FASEB J, August 1, 2002; 16(10): 1163 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Haluzik, K. R. Dietz, J. K. Kim, B. Marcus-Samuels, G. I. Shulman, O. Gavrilova, and M. L. Reitman Adrenalectomy Improves Diabetes in A-ZIP/F-1 Lipoatrophic Mice by Increasing Both Liver and Muscle Insulin Sensitivity Diabetes, July 1, 2002; 51(7): 2113 - 2118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Chou, M. Haluzik, C. Gregory, K. R. Dietz, C. Vinson, O. Gavrilova, and M. L. Reitman WY14,643, a Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) Agonist, Improves Hepatic and Muscle Steatosis and Reverses Insulin Resistance in Lipoatrophic A-ZIP/F-1 Mice J. Biol. Chem., June 28, 2002; 277(27): 24484 - 24489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Mauvais-Jarvis, J. Wolfsdorf, A. Sadeghi-Nejad, B. Senior, A. Inui, E. A. Oral, E. Ruiz, and P. Gorden Leptin-Replacement Therapy in Lipodystrophy N. Engl. J. Med., June 20, 2002; 346(25): 2008 - 2010. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Valet, G. Tavernier, I. Castan-Laurell, J. S. Saulnier-Blache, and D. Langin Understanding adipose tissue development from transgenic animal models J. Lipid Res., June 1, 2002; 43(6): 835 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Fischer, P. Moller, L. Bindl, I. Melzner, H. Tornqvist, K.-M. Debatin, and M. Wabitsch Induction of Adipocyte Differentiation by a Thiazolidinedione in Cultured, Subepidermal, Fibroblast-Like Cells of an Infant with Congenital Generalized Lipodystrophy J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2384 - 2390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-Y. Lin, D. A. Higginbotham, R. L. Judd, and B. D. White Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1084 - E1091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Endocr. Rev., April 1, 2002; 23(2): 201 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. HIDAKA, H. YOSHIMATSU, S. KONDOU, Y. TSURUTA, K. OKA, H. NOGUCHI, K. OKAMOTO, H. SAKINO, Y. TESHIMA, T. OKEDA, et al. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats FASEB J, April 1, 2002; 16(6): 509 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Oral, V. Simha, E. Ruiz, A. Andewelt, A. Premkumar, P. Snell, A. J. Wagner, A. M. DePaoli, M. L. Reitman, S. I. Taylor, et al. Leptin-Replacement Therapy for Lipodystrophy N. Engl. J. Med., February 21, 2002; 346(8): 570 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Carlyle, O. B. Jones, J. J. Kuo, and J. E. Hall Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity Hypertension, February 1, 2002; 39(2): 496 - 501. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |